{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:28:13Z","timestamp":1791260893122,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Non-Hodgkin lymphoma (NHL) of the lip is extremely rare. It is usually indolent and in early stages a local approach is often indicated. We present a case report of a patient with extranodal NHL of the lip treated with chemotherapy and low-dose radiation treatment (RT). The patient was affected by B-cell NHL of the marginal zone, Stage IAE. After a few months of observation with progressive disease, the patient was submitted to two cycles of chemotherapy with no response. Therefore, he was treated with very low-dose RT consisting of two fractions of 2 Gy. Complete response was observed and after 1-year follow-up, persistent complete response was recorded. In cases of localized disease, especially in patients with comorbidities of poor performance status (PS), low-dose RT can be an appropriate approach with excellent outcomes in terms of effectiveness and low risk of toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T11:40:57Z","timestamp":1546256457000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip"],"prefix":"10.4103","volume":"14","author":[{"given":"Lavinia","family":"Bianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Dario","family":"Solla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Parvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bollito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Riccardo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia Ruo","family":"Redda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20241211","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R4-9-20241211","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/2040620712453595","article-title":"Marginal zone lymphoma: old, new, targeted, and epigenetic therapies","volume":"3","author":"Joshi","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"R5-9-20241211","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B-cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"key":"R7-9-20241211","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"key":"R8-9-20241211","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin\u2019s lymphoma classification project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J Clin Oncol"},{"key":"R9-9-20241211","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0360-3016(01)01549-8","article-title":"Stage I and II MALT lymphoma: results of treatment with radiotherapy","volume":"50","author":"Tsang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-9-20241211","first-page":"272","article-title":"Primary extranodal lymphomas of lip a rare manifestation in Sjogren\u2019s syndrome","volume":"8","author":"Shwetha","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"R11-9-20241211","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1067\/moe.2001.116062","article-title":"Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases","volume":"92","author":"Epstein","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R12-9-20241211","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0360-3016(00)00412-0","article-title":"Radiotherapy for primary localized (Stage I and II) non-Hodgkin\u2019s lymphoma of the oral cavity","volume":"47","author":"Sunaba","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-9-20241211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1034\/j.1600-0714.2001.300303.x","article-title":"Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma","volume":"30","author":"Yin","year":"2001","journal-title":"J Oral Pathol Med"},{"key":"R14-9-20241211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/moe.2001.116155","article-title":"Epstein-Barr virus detection in non-Hodgkin\u2019s lymphoma of the oral cavity. An immunocytochemical and in situ hybridization study","volume":"92","author":"Leong","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R15-9-20241211","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0971-5851.89776","article-title":"Isolated primary extranodal lymphoma of the oral cavity: a series of 15 cases and review of literature from a tertiary care cancer centre in India","volume":"32","author":"Shah","year":"2011","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R17-9-20241211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2017.72.2835","article-title":"Extranodal marginal zone lymphoma: no longer just a sidekick","volume":"35","author":"Kamdar","year":"2017","journal-title":"J Clin Oncol"},{"key":"R18-9-20241211","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol"},{"key":"R19-9-20241211","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijrobp.2010.10.013","article-title":"Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma","volume":"81","author":"Chan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-9-20241211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900120102","article-title":"Potential role for low-dose limited-field radiation therapy (2\u00d72 Grays) in advanced low-grade non-Hodgkin lymphomas","volume":"12","author":"Ganem","year":"1994","journal-title":"Hematol Oncol"},{"key":"R21-9-20241211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2012.12.024","article-title":"Low-dose involved-field radiation in the treatment of non-Hodgkin lymphoma: predictors of response and treatment failure","volume":"86","author":"Russo","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-9-20241211","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 noninferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"R23-9-20241211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-8140(97)00148-5","article-title":"In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin\u2019s lymphomas","volume":"46","author":"Dubray","year":"1998","journal-title":"Radiother Oncol"},{"key":"R24-9-20241211","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijrobp.2010.06.056","article-title":"Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks","volume":"78","author":"Ganem","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-9-20241211","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hed.24717","article-title":"Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma","volume":"39","author":"Pinnix","year":"2017","journal-title":"Head Neck"},{"key":"R26-9-20241211","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijrobp.2010.12.062","article-title":"Low-dose radiotherapy in indolent lymphoma","volume":"81","author":"Rossier","year":"2011","journal-title":"Int J Radiation Oncology Biol Phys"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387618301213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387618301213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2018.12.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:40:56Z","timestamp":1787838056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2018.12.002"}},"subtitle":["Case report and literature review"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2018.12.002","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}